<?xml version="1.0" encoding="UTF-8"?>
<ref id="tbed13734-bib-0080">
 <mixed-citation publication-type="journal" id="tbed13734-cit-0080">
  <string-name>
   <surname>Thanh</surname>, 
   <given-names>L. T.</given-names>
  </string-name>, 
  <string-name>
   <surname>Andreadakis</surname>, 
   <given-names>Z.</given-names>
  </string-name>, 
  <string-name>
   <surname>Kumar</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Gómez</surname>, 
   <given-names>R. R.</given-names>
  </string-name>, 
  <string-name>
   <surname>Tollefsen</surname>, 
   <given-names>S.</given-names>
  </string-name>, 
  <string-name>
   <surname>Saville</surname>, 
   <given-names>M.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Mayhew</surname>, 
   <given-names>S.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>The COVID‐19 vaccine development landscape</article-title>. 
  <source xml:lang="en">Nature Reviews Drug Discovery</source>, 
  <volume>19</volume>, 
  <fpage>305</fpage>–
  <lpage>306</lpage>. 
  <pub-id pub-id-type="doi">10.1038/d41573-020-00073-5</pub-id>
 </mixed-citation>
</ref>
